A podcast featuring
biotech career journeys

Fang grew up in Hohhot, Inner Mongolia, China, and began his biotech journey as a PhD student in genetics at Fudan University. After graduation, he moved to the U.S. to pursue cancer research. He now works at Harvard Medical School's Beth Israel Deaconess Medical Center with prostate cancer expert Steven Balk, focusing on overcoming chemotherapy resistance in terminal-stage patients. Outside the lab, Fang is an avid rower and a fan of classic music — you might spot him on the Charles River or in the Boston Symphony Hall.

Yossef grew up in Staten Island, New York before moving to Baltimore to attend Johns Hopkins University. Now as a PhD candidate at Harvard University in the Beroukhim Lab, Yossef is doing research on adult and pediatric brain cancers. When he's not looking (and failing) to find good bagels or pizza in the Boston area, Yossef likes to play soccer and basketball, listen to modern rap and R&B music, and watch a Sci-Fi movie or TV show.

Rui is a research fellow at Massachusetts General Hospital, affiliated with Harvard Medical School and the Broad Institute of MIT and Harvard. He earned his Ph.D. in Immunology from McGill University. Rui's research currently focuses on the mechanisms of autoimmune diseases.

Jennifer trained as a bioengineer at McGill and is now a Harvard PhD candidate dissecting how proteins work and how to better design new ones. When she's not in the lab, you'll find her trying new restaurants, swinging a tennis racquet, or speed-solving a cube, before heading out for a Boston day trip or ski run.

Malvika is a Ph.D. candidate in the Program in Neuroscience at Harvard Medical School and a researcher in the lab of Dr. David Ginty. Her work focuses on how high-frequency vibrotactile signals are integrated into the ascending auditory pathway, uncovering how somatosensory information shapes thalamic and cortical processing in both hearing and congenitally deaf mice. Using multi-electrode electrophysiology, circuit-level analysis, and cross-modal experimental design, she investigates how sensory systems adapt and reorganize in response to altered input. She is passionate about bridging fundamental neuroscience with therapeutic innovation, with long-term career interests at the intersection of academia, biotech, and venture investing.

Tanner is a Ph.D. student in the Harvard Chemical Biology Program and Co-Director of Corporate Relations in the Harvard Biotech Club. Before joining the club, Tanner developed next-generation sequencing tools for detecting cancer biomarkers in the lab of Dr. Chuan He at the University of Chicago. Tanner's work contributed to the Ultrafast Bisulfite Sequencing (UBS-seq) and Ultra-mild Bisulfite Sequencing (UMBS-seq) methods published in Nature Biotechnology and Nature Communications. These technologies later spun out the biotech startup Ellis Bio. Tanner has a passion for epigenetics and translational biotechnology with career interests that lie at the intersection of academia and industry.

Sherin grew up in Urumqi, Xinjiang, China, before moving to California to attend UC Santa Cruz. After graduating, she spent several years at UCSF working on translational pediatric leukemia research. Now as a PhD candidate at Harvard University in the Van Allen Lab, Sherin continues to pursue translational cancer biology research, with a focus on kidney cancer in adults. Outside the lab, she can usually be found boxing, lifting, sleeping, reading, eating spicy food, or deep into a movie marathon.